Dr Reddys Laboratories informs about disclosure

25 Feb 2022 Evaluate

Further to its announcements dated February 2 and 8, 2022, on the acquisition of German medical cannabis firm Nimbus Health GmbH by its subsidiary Reddy Holding GmbH, Dr Reddys Laboratories has informed that the acquisition has now been completed. Nimbus Health GmbH is now a wholly owned step-down subsidiary of the Company with effect from February 24, 2022. The required details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’) read with the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, as already disclosed to the exchanges on February 8, 2022, are enclosed as an Annexure to this intimation.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1258.55 -15.70 (-1.23%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.